Press release
Leading Growth Driver in the Engerix-B Market in 2025: Rising Prevalence Of Hepatitis B Virus Infection Driving Growth In The Market Driver's Influence
Engerix-B Market
Rapid expansion is witnessed in the Engerix-B market with a HCAGR of $XX in recent years. The market value is expected to rise from $XX million in 2024 to $XX million in 2025, exhibiting a compound annual growth rate (CAGR) of $XX%. The historical growth of this market has been driven by factors such as the rising incidence of hepatitis B, expansive government vaccination initiatives, amplified awareness of hepatitis B, enhancements in healthcare facilities, and increasing global travel and migration trends.
Predictions indicate that the market size of Engerix-B will experience an augmentation of $XX in the impending years, escalating to a value of $XX million by 2029 with a Compound Annual Growth Rate (CAGR) of $XX%. The foreseen growth in this period is attributed to numerous factors including the expansion of vaccine access in emerging markets, government-supported immunization programs, an accentuating emphasis on preventive healthcare and vaccination and an escalating awareness of chronic hepatitis B. The forecast period also showcases significant trends such as the increasing inclination towards combination vaccines, the growing use of digital health technologies in vaccine administration, the application of novel delivery systems, and government-led mass immunization initiatives and awareness campaigns, alongside rising governmental initiatives and policies.
What Are the Forces Behind the Rapid Growth of the Engerix-B Market?
The increasing occurrence of hepatitis B virus (HBV) infection is anticipated to boost the engerix-B market's expansion in the future. HBV infection, caused by HBV itself, is a serious condition that could lead to chronic disease, detrimental effects on the liver, and a heightened probability of liver cancer. Contributing factors to HBV infection's proliferation include unprotected sex, contact between blood, inadequate immunization, and weakened immune system. The composition of Engerix-B includes a harmless variant of the HBV surface antigen that prompts the immune system to secure protection against the virus, providing enduring immunity, thereby lowering the possibility of HBV infection and related complications. For example, the New York State Department of Health, a US government arm, reported an 11% rise in cases of chronic hepatitis B in 2022 compared to 2021, with 1,984 new incidents in November 2023. Hence, the escalating occurrence of HBV infections is fuelling the surge of the engerix-B market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20056&type=smp
Who Are the Dominant Companies Influencing Engerix-B Market Trends?
Major companies operating in the engerix-b market include GlaxoSmithKline plc.
What Are the Different Segmentations in the Engerix-B Market?
The engerix-b market covered in this report is segmented -
1) By Indication: Prevention Of Hepatitis B Virus (HBV) Infection, Chronic Hepatitis B Prevention, Healthcare Workers And High-Risk Populations, Post-Exposure Prophylaxis
2) By Distribution Channel: Hospitals, Clinics, Vaccination Centers, Pharmacies
3) By End-Use: Private Healthcare Providers, Long-Term Care Facilities, Educational Institutions
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/engerix-b-global-market-report
Which Region Is at the Forefront of the Engerix-B Market?
North America was the largest region in the engerix-B market in 2024. The regions covered in the engerix-b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Engerix-B Global Market Report?
- Market Size Analysis: Analyze the engerix-b Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the engerix-b market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall engerix-b market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the engerix-b market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20056
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Engerix-B Market in 2025: Rising Prevalence Of Hepatitis B Virus Infection Driving Growth In The Market Driver's Influence here
News-ID: 3874709 • Views: …
More Releases from The Business Research Company
How to Forecast Revenue and Expenses Accurately in Dynamic Markets
In hyper-dynamic markets, financial forecasts cannot be static they must be living, adaptive models. This article shows how businesses can combine internal data, market intelligence, and scenario design to forecast with confidence.
Why Traditional Forecasting Breaks Down
. Latency: by the time data is compiled, conditions have shifted
. Blind spots: competitors, regulatory changes, supply constraints left out
. Rigidity: single-scenario approach fails in volatile environments
Plan Your Finances Strategically…
How Businesses Can Reduce Risk When Expanding Into New Markets
Risk doesn't vanish with more data; it shrinks with better questions, stronger validation, and staged commitments. This article lays out a risk-down approach The Business Research Company uses to help clients expand confidently combining custom research, CI, and governance.
Why risk management is central to market entry
. Asymmetric information: Local players know the terrain; new entrants don't.
. Irreversibility: Some commitments (capex, exclusivity) are hard to unwind.
. Hidden…
Global Blood Market Growth Accelerates: Strategic Forecast Predicts $11.2 Billio …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Blood Industry Market Size Be by 2025?
The overall valuation of the blood market has experienced robust expansion lately, projected to climb from $8.32 billion in the year 2024 to $8.84 billion by 2025, reflecting a consistent annual growth rate (CAGR) of 6.3% across that time…
Emerging Trends to Reshape the Global Bioinformatics In In-Vitro Diagnostics (IV …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market valuation for bioinformatics within in-vitro diagnostics (ivd) testing has demonstrated significant upward momentum over the past few years, projected to increase from $93.02 billion in 2024 to $98.89 billion…
More Releases for HBV
Emerging Hepatitis B Virus (HBV) Market Trends: Rising Emphasis On Highly Sensit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Hepatitis B Virus (HBV) Market Size Growth Forecast: What to Expect by 2025?
The market for the hepatitis B virus (HBV) has expanded significantly in the last few years. The market is set to grow from its size of $6.71 billion in 2024 to an anticipated $7.37 billion in…
HIV/HBV/HCV Test Kits Market - Break the chain: Detect and prevent HIV, HBV, and …
Newark, New Castle, USA: The "HIV/HBV/HCV Test Kits Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
HIV/HBV/HCV Test Kits Market: https://www.growthplusreports.com/report/hivhbvhcv-test-kits-market/8774
This latest report researches the industry structure,…
Hepatitis B Virus [HBV] Treatment market ready to register a 5.30% CAGR
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Executive Summary -:
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada,…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
Rising Prevalence of HBV and HCV Drives the Global Hepatitis Diagnostics Market
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E.…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
